According to persons familiar with the situation, Indian vaccine maker Bharat Biotech International Ltd. is contemplating an IPO that might garner over $500 million.
The individuals, who asked not to be named in order to discuss a private subject, added that discussions are still going on and that the deal’s specifics, such as its amount and timing, could change. When asked for comment, Bharat Biotech did not immediately reply.
Since its founding in 1996, Bharat Biotech claims to have distributed over 9 billion vaccines globally. Its products include hepatitis B and Covid-19 vaccinations, as well as burn and diarrhea treatments.
After two years of record fundraising, the Indian market for first-time share sales has started 2026 slowly. Uneven foreign inflows, uncertain global trade, and sluggish earnings growth have all put pressure on stocks. Jio Platforms Ltd., a wireless carrier, National Stock Exchange of India Ltd., and real estate companies are among the companies with significant upcoming offerings.
